U.S. Senate · 118th Congress · S. 1522
S. 1522
A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Roger MarshallR-KS
- Introduced
- May 10, 2023, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.